NASDAQ: CAI
Caris Life Sciences Inc Stock Ownership - Who owns Caris Life Sciences?

Insider buying vs selling

Have Caris Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian J. BrilleVChair;EVP2026-09-17400,000$30.33
$12.13MSell
Brian J. BrilleVChair;EVP2026-09-17400,000$2.44
$976.00kBuy
David Baxley SpetzlerPres2026-09-04119,212$24.76
$2.95MSell
David Baxley SpetzlerPres2026-09-04250,000$2.44
$610.00kBuy
David Baxley SpetzlerPres2026-09-031,000,000$2.44
$2.44MBuy
David Baxley SpetzlerPres2026-09-0384,900$25.32
$2.15MSell
David Baxley SpetzlerPres2026-09-03393,100$24.76
$9.73MSell
George PosteDirector2026-05-291,600$15.62
$24.99kBuy
Jonathan Kenneth Charles KnowlesDirector2026-05-291,600$15.62
$24.99kBuy
Brian J. BrilleVice Chairman and Executive Vice President2026-05-1513,987$15.25
$213.30kSell

1 of 3

CAI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CAI insiders and whales buy or sell their stock.

CAI Shareholders

What type of owners hold Caris Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David D. Halbert49.49%139,863,002$4.32BInsider
Tssp Subfund Holdco LLC8.63%24,385,399$754.00MInsider
Peter M. Castleman7.45%21,054,620$651.01MInsider
J H Whitney VI L P7.17%20,256,615$626.33MInsider
Adapt I Ltd6.00%16,943,232$523.88MInsider
Jon Halbert1.44%4,082,891$126.24MInsider
Brian J. Brille0.61%1,730,303$53.50MInsider
David Baxley Spetzler0.42%1,182,871$36.57MInsider
George Poste0.19%529,431$16.37MInsider
Laura I. Johansen0.12%343,897$10.63MInsider

1 of 3

CAI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CAI0.05%81.85%Net BuyingNet Buying
PRAX0.12%50.28%Net SellingNet Buying
PCVX0.11%13.61%Net SellingNet Selling
ABVX0.07%0.00%
TGTX0.07%48.64%Net SellingNet Selling

Caris Life Sciences Stock Ownership FAQ

Who owns Caris Life Sciences?

Caris Life Sciences (NASDAQ: CAI) is owned by 0.05% institutional shareholders, 81.85% Caris Life Sciences insiders, and 18.09% retail investors. David D. Halbert is the largest individual Caris Life Sciences shareholder, owning 139.86M shares representing 49.49% of the company. David D. Halbert's Caris Life Sciences shares are currently valued at $4.19B.

If you're new to stock investing, here's how to buy Caris Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.